Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 23
1989 63
1990 40
1991 30
1992 79
1993 45
1994 35
1995 31
1996 39
1997 25
1998 34
1999 43
2000 28
2001 24
2002 23
2003 21
2004 18
2005 27
2006 33
2007 25
2008 18
2009 28
2010 22
2011 26
2012 17
2013 24
2014 28
2015 17
2016 18
2017 28
2018 24
2019 27
2020 31
2021 20
2022 20
2023 23
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

999 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean malaquin OR Lomefloxacin (1,162 results)?
Lomefloxacin.
Al-Wabli RI. Al-Wabli RI. Profiles Drug Subst Excip Relat Methodol. 2017;42:193-240. doi: 10.1016/bs.podrm.2017.02.004. Epub 2017 Mar 31. Profiles Drug Subst Excip Relat Methodol. 2017. PMID: 28431777
Lomefloxacin is a second-generation difluorinated broad-spectrum quinolone antibiotic. ...In addition, the uses, pharmacokinetics, and chemical synthesis of lomefloxacin are described....
Lomefloxacin is a second-generation difluorinated broad-spectrum quinolone antibiotic. ...In addition, the uses, pharmacokinetics, an …
Lomefloxacin clinical pharmacokinetics.
Freeman CD, Nicolau DP, Belliveau PP, Nightingale CH. Freeman CD, et al. Clin Pharmacokinet. 1993 Jul;25(1):6-19. doi: 10.2165/00003088-199325010-00002. Clin Pharmacokinet. 1993. PMID: 8394795 Review.
Like most fluoroquinolones, lomefloxacin can chelate with heavy metals. However, this interaction can be eliminated by administering lomefloxacin 2h before the cation-containing products. ...However, patients with liver disease do not require alterations in lomef …
Like most fluoroquinolones, lomefloxacin can chelate with heavy metals. However, this interaction can be eliminated by administering …
Ciprofloxacin, lomefloxacin, or levofloxacin as treatment for chronic osteomyelitis.
Greenberg RN, Newman MT, Shariaty S, Pectol RW. Greenberg RN, et al. Antimicrob Agents Chemother. 2000 Jan;44(1):164-6. doi: 10.1128/AAC.44.1.164-166.2000. Antimicrob Agents Chemother. 2000. PMID: 10602739 Free PMC article. Clinical Trial.
The efficacy and safety of three oral fluoroquinolones (lomefloxacin, levofloxacin, and ciprofloxacin) for the treatment of chronic osteomyelitis were analyzed. ...Lomefloxacin was effective therapy for five of seven (71%) patients, and ciprofloxacin was effective t …
The efficacy and safety of three oral fluoroquinolones (lomefloxacin, levofloxacin, and ciprofloxacin) for the treatment of chronic o …
Photosensitivity induced by lomefloxacin versus other fluoroquinolones: A meta-analysis.
Eljaaly K, Alkhalaf A, Alhifany AA, Alshibani M. Eljaaly K, et al. J Infect Chemother. 2020 Jun;26(6):535-539. doi: 10.1016/j.jiac.2020.01.005. Epub 2020 Feb 17. J Infect Chemother. 2020. PMID: 32081646
Lomefloxacin may be more likely than other fluoroquinolones to cause photosensitivity. ...This meta-analysis of RCTs found significantly higher photosensitivity with lomefloxacin compared to other fluoroquinolones. Considering this finding and given its lack of addi …
Lomefloxacin may be more likely than other fluoroquinolones to cause photosensitivity. ...This meta-analysis of RCTs found significan …
Bioequivalence evaluation of lomefloxacin 400 mg tablets (Lomax versus Maxaquin in healthy human volunteers.
Al-Rashood KA, Al-Khamis KI, El-Sayed YM, Al-Bella S, Al-Yamani MA, Alam SM, Dham R. Al-Rashood KA, et al. Biopharm Drug Dispos. 1999 Dec;20(9):407-10. doi: 10.1002/1099-081x(199912)20:9<407::aid-bdd199>3.0.co;2-f. Biopharm Drug Dispos. 1999. PMID: 10951428 Clinical Trial.
This study represents the results of a randomized, single dose, two-treatment, two-period crossover study in 18 healthy male volunteers to assess the bioequivalence of two tablets of 400 mg lomefloxacin. The two formulations were: Lomax(R) (Julphar, United Arab Emirates) a …
This study represents the results of a randomized, single dose, two-treatment, two-period crossover study in 18 healthy male volunteers to a …
Overview of the fluoroquinolone antibiotics.
Just PM. Just PM. Pharmacotherapy. 1993 Mar-Apr;13(2 Pt 2):4S-17S. Pharmacotherapy. 1993. PMID: 8386356 Review.
Commercially available products in the United States now include norfloxacin, ciprofloxacin, ofloxacin, enoxacin, and lomefloxacin. Although they share a common mechanism of action, they differ significantly in their antimicrobial spectrum of activity, their pharmacokineti …
Commercially available products in the United States now include norfloxacin, ciprofloxacin, ofloxacin, enoxacin, and lomefloxacin. A …
Effects of CYP1A enzyme specific inhibitor on pharmacokinetics of para-acetaminophen in Bactrian camel.
San R, Yue W, Hasi S. San R, et al. J Vet Sci. 2019 May;20(3):e12. doi: 10.4142/jvs.2019.20.e12. J Vet Sci. 2019. PMID: 31161735 Free PMC article.
Twelve Bactrian camels were divided into 2 groups, then given a single dose of p-acetaminophen only or with the enzyme inhibitor lomefloxacin. Blood samples were collected after different intervals, and p-acetaminophen concentration was determined by high-performance liqui …
Twelve Bactrian camels were divided into 2 groups, then given a single dose of p-acetaminophen only or with the enzyme inhibitor lomeflox …
The expanding role of fluoroquinolones.
Schaeffer AJ. Schaeffer AJ. Am J Med. 2002 Jul 8;113 Suppl 1A:45S-54S. doi: 10.1016/s0002-9343(02)01059-8. Am J Med. 2002. PMID: 12113871 Review.
In vitro toxicity evaluation of lomefloxacin-loaded MCM-41 mesoporous silica nanoparticles.
Tzankova V, Aluani D, Yordanov Y, Valoti M, Frosini M, Spassova I, Kovacheva D, Tzankov B. Tzankova V, et al. Drug Chem Toxicol. 2021 May;44(3):238-249. doi: 10.1080/01480545.2019.1571503. Epub 2019 Mar 1. Drug Chem Toxicol. 2021. PMID: 30822164
Lomefloxacin (LF) is interesting as a model molecule from a safety point of view because of its high potential for serious adverse drug effects (i.e. phototoxic reactions). ...The findings from the study indicated that empty MCM-41 (0.1-1.0 mg/ml) showed a low cytotoxic po …
Lomefloxacin (LF) is interesting as a model molecule from a safety point of view because of its high potential for serious adverse dr …
999 results